Clinical trial
Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)
NCT00090181 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00090181 |
|---|---|
| Title | Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED) |
| Official title | A Double-Blind, Parallel-group, 4-Week Trial to Assess the Efficacy and Safety of Etoricoxib 60 mg and Diclofenac 150 mg in Patients With Chronic Low Back Pain |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Low Back Pain |
| Intervention type | Drug |
| Interventions | MK0663, etoricoxib / Duration of Treatment: 4 weeks, Comparator: diclofenac / Duration of Treatment: 4 weeks |
| Enrollment | 401 |
| Start date | Jun 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Aug 27, 2004 |
| Last update posted | Feb 15, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: